Shkreli Price Increase Has Stuck

Media Summary: Dec.23 -- Former Turing Pharmaceuticals CEO Martin A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the Several members of Congress are demanding to know why the

Shkreli Price Increase Has Stuck - Detailed Analysis & Overview

Dec.23 -- Former Turing Pharmaceuticals CEO Martin A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the Several members of Congress are demanding to know why the December 23, 2016 Former Turing Pharmaceuticals CEO Martin The young former head of a pharmaceutical company in the U.S. was in the hot seat in front of the United States' Congress today ... The Turing Pharmaceuticals CEO promised to lower the drug

The Fiscal Times Columnist Liz Peek and FBN's Charlie Gasparino on the arrest of former Turing Pharmaceuticals CEO Martin ...

Photo Gallery

Shkreli: Price Increase Has Stuck, Happy With That

Martin Shkreli must return $64M from Daraprim price hike | Top 10

American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime

CEO defends raising drug price 5,000 percent

Despite promise, pill cost has not dropped

Infamous ex-pharma CEO Martin Shkreli weighs in on EpiPen price hike

Martin Shkreli Interview (with Pepe the Frog Pin): "Price Increase Has Stuck, Happy With That"

Martin Shkreli not the first to hike drug prices

Martin Shkreli smirks at questions over his price hike of lifesaving drug Daraprim

Big pharma head Shkreli won't answer Congress on 5000% drug price hike

Martin Shkreli Is At It Again, Refuses To Lower Price Of $750 Drug - Newsy

Students Recreate Shkreli's Overpriced Drug Daraprim For $2 | TIME

View Detailed Profile

Shkreli: Price Increase Has Stuck, Happy With That

Shkreli: Price Increase Has Stuck, Happy With That

Dec.23 -- Former Turing Pharmaceuticals CEO Martin

Martin Shkreli must return $64M from Daraprim price hike | Top 10

Martin Shkreli must return $64M from Daraprim price hike | Top 10

The federal judge also barred

American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime

American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime

Hear Martin

CEO defends raising drug price 5,000 percent

CEO defends raising drug price 5,000 percent

A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the

Despite promise, pill cost has not dropped

Despite promise, pill cost has not dropped

After outrage over the

Infamous ex-pharma CEO Martin Shkreli weighs in on EpiPen price hike

Infamous ex-pharma CEO Martin Shkreli weighs in on EpiPen price hike

Several members of Congress are demanding to know why the

Martin Shkreli Interview (with Pepe the Frog Pin): "Price Increase Has Stuck, Happy With That"

Martin Shkreli Interview (with Pepe the Frog Pin): "Price Increase Has Stuck, Happy With That"

December 23, 2016 Former Turing Pharmaceuticals CEO Martin

Martin Shkreli not the first to hike drug prices

Martin Shkreli not the first to hike drug prices

Infamous pharma ex-CEO Martin

Martin Shkreli smirks at questions over his price hike of lifesaving drug Daraprim

Martin Shkreli smirks at questions over his price hike of lifesaving drug Daraprim

Infamous CEO Martin

Big pharma head Shkreli won't answer Congress on 5000% drug price hike

Big pharma head Shkreli won't answer Congress on 5000% drug price hike

The young former head of a pharmaceutical company in the U.S. was in the hot seat in front of the United States' Congress today ...

Martin Shkreli Is At It Again, Refuses To Lower Price Of $750 Drug - Newsy

Martin Shkreli Is At It Again, Refuses To Lower Price Of $750 Drug - Newsy

The Turing Pharmaceuticals CEO promised to lower the drug

Students Recreate Shkreli's Overpriced Drug Daraprim For $2 | TIME

Students Recreate Shkreli's Overpriced Drug Daraprim For $2 | TIME

Sydney school kids just made Martin

Shkreli claims drug price hikes triggered arrest

Shkreli claims drug price hikes triggered arrest

The Fiscal Times Columnist Liz Peek and FBN's Charlie Gasparino on the arrest of former Turing Pharmaceuticals CEO Martin ...